These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persistent adenovirus-mediated thymidine kinase gene expression in ovarian cancer cells increases cell killing efficacy over time. Kieback DG; Delvoux B; Romano A; Ollig S; Fischer DC Anticancer Res; 2008; 28(5A):2569-75. PubMed ID: 19035280 [TBL] [Abstract][Full Text] [Related]
4. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. Tong XW; Engehausen DG; Kaufman RH; Agoulnik I; Contant C; Freund CT; Oehler MK; Kim TE; Hasenburg A; Woo SL; Kieback DG Anticancer Res; 1998; 18(2A):713-8. PubMed ID: 9615710 [TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer. Tong X; Engehausen DG; Freund CT; Agoulnik I; Oehler MK; Kim TE; Hasenburg A; Guo Z; Contant CF; Woo SL; Kieback DG Hybridoma; 1999 Feb; 18(1):93-7. PubMed ID: 10211795 [TBL] [Abstract][Full Text] [Related]
6. [Animal experiment on gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and ganciclovir administration in vivo]. Tong X; Sei W; Gu M Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):712-4. PubMed ID: 9772431 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir. Tong XW; Block A; Chen SH; Woo SL; Kieback DG Anticancer Res; 1996; 16(4A):1611-7. PubMed ID: 8712678 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated thymidine kinase gene therapy and coxsackie adenovirus receptor expression in ovarian cancer cells. Kieback DG Cancer Genomics Proteomics; 2008; 5(6):311-8. PubMed ID: 19287072 [TBL] [Abstract][Full Text] [Related]
12. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
13. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958 [TBL] [Abstract][Full Text] [Related]
14. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296 [TBL] [Abstract][Full Text] [Related]
15. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells]. Zhou JF; Chen G; Lu YP; Wang SX; Ma D Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter]. Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830 [TBL] [Abstract][Full Text] [Related]
20. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model]. Zhou JF; Chen G; Lu YP; Wang SX; Ma D Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]